- Home
- Services
- united kingdom
- central nervous system
Show results for
Refine by
Central Nervous System Services In United Kingdom
6 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Insults to the central nervous system can lead to severe motor impairments in gait or fine motor skills. To develop therapies for motor dysfunction, animal models which have a disease pathophysiology comparable to the clinical population are used. Smaller animals such as rodents are preferred by scientists due to various reasons, such as high ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Rodent models of Central Nervous System (CNS) disorders are widely used to explore pathology and molecular mechanisms, identify potential biomarkers, and to assess the therapeutic utility and estimate safety margins of new disease-specific drugs. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Multiple Sclerosis (MS) is a chronic inflammatory neurodegenerative disease of the central nervous system (CNS). Experimental autoimmune encephalomyelitis (EAE) is the most common animal model of human MS as it is especially useful to investigate neuroinflammatory pathways and often serves as a "proof-of-principle" model for the efficacy of novel ...
by:Envigo based inCambridgeshire, UNITED KINGDOM
In addition, safety pharmacology studies must be performed to evaluate possible effects on the cardiovascular, respiratory and central nervous ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
During ReGen’s discussions with potential licensing partners in 2004, it became apparent that a product based on the Colostrinin™ complex, as a whole, was more commercially attractive as a nutraceutical, rather than as a pharmaceutical. It was decided, therefore, to develop the original formulation of Colostrinin™ as a ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. We have also invested in the field of multiplexing, using ...